Cargando…
Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma
As the most common cancer in men, prostate cancer is molecularly heterogeneous. Contributing to this heterogeneity are the poorly understood metabolic adaptations of the two main types of prostate cancer, i.e., adenocarcinoma and small cell neuroendocrine carcinoma (SCNC), the latter being more aggr...
Autores principales: | Gao, Bei, Lue, Hui-Wen, Podolak, Jennifer, Fan, Sili, Zhang, Ying, Serawat, Archana, Alumkal, Joshi J., Fiehn, Oliver, Thomas, George V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572715/ https://www.ncbi.nlm.nih.gov/pubmed/31035489 http://dx.doi.org/10.3390/metabo9050082 |
Ejemplares similares
-
Nitrene Radical Intermediates in Catalytic Synthesis
por: Kuijpers, Petrus F., et al.
Publicado: (2017) -
α‐Imino Gold Carbene Intermediates from Readily Accessible Sulfilimines: Intermolecular Access to Structural Diversity
por: Tian, Xianhai, et al.
Publicado: (2020) -
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
por: Zhao, Jiangsha, et al.
Publicado: (2017) -
Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials
por: Alkim, Emel, et al.
Publicado: (2023) -
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021)